HappeningToo topic
Bortezomib reports
Browse community reports connected to Bortezomib. These reports can show that other people are describing similar experiences, but they do not prove that Bortezomib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
27 problems
Abdominal Pain while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and abdominal pain appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and back pain appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and chills appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and constipation appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and cough appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and decreased appetite appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and dehydration appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and diarrhea appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and dizziness appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and fatigue appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and headache appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and hypotension appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and insomnia appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and itching appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and malaise appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and muscle spasms appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and muscular weakness appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and nausea appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and pain appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and peripheral swelling appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and rash appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and shortness of breath appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and tingling or pins and needles appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and tremor appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and vomiting appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and weakness appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Bortezomib
FDA FAERS contains adverse-event reports in which Bortezomib and weight decreased appear together. This does not establish that Bortezomib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →